Symptoms & Early Warning Signs
Common indicators and clinical warning signs
Note: Early-stage pancreatic cancer often has no symptoms or vague symptoms. By the time symptoms appear, the cancer is often advanced. High-risk individuals should discuss screening with their doctor.
Diagnosis Pathway
Step-by-step clinical evaluation and staging workflow
Medical history and physical examination
Blood tests (liver function, CA 19-9 tumor marker)
Imaging tests (CT scan with contrast, MRI, or endoscopic ultrasound)
Biopsy (via endoscopic ultrasound, CT-guided, or surgical)
Pathology report and staging
Assessment of resectability (whether surgery is possible)
Staging Explained
How tumor size, lymph node involvement, and metastasis are graded
Carcinoma in situ (abnormal cells only in pancreatic lining)
Cancer confined to pancreas, ≤4cm (IA) or >4cm (IB)
Cancer spread to nearby lymph nodes or nearby tissues, but not distant sites
Cancer spread to major blood vessels or multiple lymph nodes, but not distant organs
Metastatic (spread to distant organs like liver, lungs, peritoneum)
Treatment Options
Standard of care modalities according to NCCN clinical guidelines
Surgery (Whipple Procedure)
Pancreaticoduodenectomy (Whipple) removes head of pancreas, part of small intestine, gallbladder, and bile duct. Only possible if cancer hasn't spread and doesn't involve major blood vessels. Requires high-volume surgical center.
Distal Pancreatectomy
Removal of tail and body of pancreas (for tumors in these areas). May include removal of spleen.
Chemotherapy
Used before surgery (neoadjuvant), after surgery (adjuvant), or for advanced disease. Common regimens: FOLFIRINOX, gemcitabine + nab-paclitaxel. Usually 6 months of treatment.
Radiation Therapy
May be used with chemotherapy (chemoradiation) before or after surgery, or for locally advanced disease. Typically 5-6 weeks of daily treatment.
Targeted Therapy
For advanced pancreatic cancer with specific genetic mutations. Examples: erlotinib (with gemcitabine), olaparib (for BRCA mutations). Requires genetic testing.
Immunotherapy
Limited use. May be considered for advanced pancreatic cancer with specific genetic features (MSI-H or dMMR), though this is rare in pancreatic cancer.
Treatment Cost Comparisons
Transparent out-of-pocket benchmarks for India and US healthcare centers
Treatment Cost in India
- Whipple procedure: ₹5-20 lakhs
- Distal pancreatectomy: ₹3-12 lakhs
- Chemotherapy (per cycle): ₹30,000 - ₹2,00,000
- Radiation therapy: ₹2-5 lakhs
- Targeted therapy: ₹60,000 - ₹3 lakhs per month
- Complete treatment: ₹10-40 lakhs (depending on stage and type)
Treatment Cost in US
- Whipple procedure: $50,000 - $150,000
- Distal pancreatectomy: $40,000 - $120,000
- Chemotherapy: $20,000 - $250,000 (depending on duration and drugs)
- Radiation therapy: $20,000 - $70,000
- Targeted therapy: $8,000 - $20,000 per month
- Complete treatment: $80,000 - $400,000+
Frequently Asked Questions about Pancreatic Cancer
This guide provides verified clinical insights based on established oncological literature (NCCN, ASCO, ESMO). It is not a substitute for professional medical diagnosis or personalized treatment planning. Always consult your qualified oncology specialist before initiating treatment.